| Position | Action |
|---|---|
| Pullback to $144-146 with 200 SMA holding on a daily close and RSI > 45 | Add sized at 25-33% of normal |
| Confirmed close above $151.62 followed by successful retest within 5-10 sessions on volume | Add sized at 25-33% of normal |
| First failed bounce at $148-149 on volume >7M | Trim readiness |
PG is coiled for a meaningful re-rating driven by the transformative Thorne acquisition entering a 5-8% growth category with superior margins, a technically constructive setup with MA compression and fading bearish momentum, and macro tailwinds favoring defensives in a "higher for longer" environment—all at a forward P/E discount to its own historical multiple.
| Indicator | Value | Signal |
|---|---|---|
| Close | $146.97 | neutral |
| 10 EMA | $146.64 | neutral |
| 50 SMA | $146.73 | bullish |
| 200 SMA | $145.90 | bearish |
| RSI (14) | 50.24 | neutral |
| MACD | -0.18 | bearish |
| MACD Signal | -0.09 | bearish |
| MACD Histogram | -0.09 | bearish |
| Bollinger Upper Band | $150.27 | — |
| Bollinger Middle Band | $146.98 | — |
| Bollinger Lower Band | $143.69 | — |
| ATR (14) | $3.55 | neutral |
Support: 145.9 · 143.69 · 140 · 141 | Resistance: 150.27 · 151.62 · 146.97
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Maintain PG position; do not add aggressively at current levels ($146.97)
Hold with tightened triggers: add only on $144-146 with 200 SMA daily-close stabilization and RSI > 45 (size 25-33% of normal, stop $143.50), or close above $151.62 with successful retest within 5-10 sessions on volume >7M. Trim readiness on first failed bounce into $148-149 on volume—the 08-04 lesson ("when support re-holds but alpha compresses negative, earlier trim-on-first-failed-bounce is better than passive Hold") is directly applicable. Time horizon tightens to 4-8 weeks with mandatory reassessment at the October Q1 FY27 print.
When: Confirmed close above $151.62 followed by successful retest within 5-10 sessions on volume
Then: Add sized at 25-33% of normal with hard stop at $143.50
PG's financial quality is exceptional and underappreciated—30%+ ROE with minimal volatility and pristine cash generation
· concedes: A +1.5% revenue print isn't going to win any growth awards on its own; FX is a translation headwind on >50% international revenue; $3.8B Thorne deal is material at ~1.1% of market cap and ~25% of FY2026 FCF; P/E of 22x and PEG of 5.57 are stretched relative to growth expectations; Gross margin compression of 100bps and operating margin slip from 24.3% to 22.7% are real concerns
PG's valuation premium (22.17x P/E, 5.57 PEG, 6.44x P/B) cannot be justified by 3% revenue growth, negative volume trends, and a desperate M&A pivot at a 5.6x markup — the coiled spring is actually a rolling-over risk asset with a declining 200 SMA confirming long-term bearish trend.
· concedes: Thorne is a legitimate strategic acquisition targeting a growth category (premium wellness/supplements); PG's cost discipline and 4.4% FCF yield demonstrate financial management skill; ROE above 30% is genuinely high and reflects brand strength; Some technical indicators (50 SMA turning up, Bollinger compression) suggest near-term stabilization is possible; Premium tier of portfolio (Olay, SK-II) has structural tailwinds from K-shaped economy winners; The dividend track record (Dividend King status) is real, even if yield is sub-Treasury
→ vs conservative: Stretched valuation thesis anchored to outdated numbers; forward P/E compression of 12% shows market already paying for earnings growth not yet realized; PEG 5.57 ignores 10x revenue acceleration from +0.3% to +3.3% in FY2026; 'bear's failed rally' at $151.62 is coiled-spring resistance, not a ceiling
→ vs neutral: 'Wait for confirmation' mentality crushes coiled-spring setups; MACD turning from -0.22 to -0.09 shows bearish momentum fading; all oscillators neutral at bottom of range = asymmetric positioning opportunity, not a reason to wait; Thorne acquisition dramatically underweighted as category-repositioning catalyst rather than binary risk
PG is at a technical inflection point with the 10 EMA, 50 SMA, and Bollinger middle band all converging near $146.70–$146.98, effectively pinning price to these moving averages with all short-term momentum oscillators flat and neutral. The 200 SMA's downward slope ($145.90) confirms a medium-term downtrend context, while Bollinger Band contraction (~$6.58 width vs prior $15+ weeks) indicates a squeeze setup awaiting directional catalyst. The stock is range-bound between $143.69 (Boll LB) and $150.27 (Boll UB), with ATR at $3.55 suggesting relatively low volatility despite modest expansion; a decisive daily close below $145.90 would invalidate the constructive 50-SMA slope and target $140.
Market Cap
$341.6 B
Share Price
~$147.0
52-Week High
$167.25
52-Week Low
$137.62
Beta
0.377
P/E (TTM)
22.17
Forward P/E
19.83
PEG Ratio
5.57
Price / Book
6.44
EPS (TTM)
$6.63
Forward EPS
$7.41
Book Value / Share
$22.84
Free Cash Flow (TTM)
$13.28 B
Market Cap / FCF
~25.7x
Total Revenue (FY2026)
$87,032 million
Revenue Growth (FY2026 YoY)
+3.3%
Cost of Revenue (FY2026)
$43,362 million
Gross Profit (FY2026)
$43,670 million
Gross Margin
50.2%
SG&A (FY2026)
$23,922 million
Operating Income (FY2026)
$19,748 million
Operating Margin
22.7%
EBITDA Normalized (FY2026)
$24,414 million
EBITDA Margin
28.0%
Net Income (FY2026)
$16,046 million
Net Margin
18.4%
Diluted EPS (FY2026)
$6.62
Diluted Share Count
2,422 million
Cash & Equivalents (FY2026)
$9,942 million
Receivables (FY2026)
$6,056 million
Inventory (FY2026)
$8,170 million
Total Current Assets (FY2026)
$26,208 million
Goodwill & Intangibles (FY2026)
$62,720 million
Net PPE (FY2026)
$25,360 million
Total Assets (FY2026)
$126,521 million
Accounts Payable (FY2026)
$16,306 million
Short-Term Debt (FY2026)
$11,297 million
Long-Term Debt (FY2026)
$22,842 million
Total Debt (FY2026)
$35,026 million
Net Debt (FY2026)
$24,197 million
Stockholders' Equity (FY2026)
$54,081 million
Debt/Equity
64.5%
Current Ratio
0.68
Operating Cash Flow (FY2026)
$19,556 million
CapEx (FY2026)
($4,409 million)
Free Cash Flow (FY2026)
$15,147 million
FCF Yield
~4.4%
Dividends Paid (FY2026)
($10,232 million)
Buybacks (FY2026)
($5,028 million)
Total Capital Return (FY2026)
~$15.3 billion
OCF / Net Income Ratio
1.22x
Return on Equity (ROE)
30.3%
Return on Assets (ROA)
10.7%
Dividend Yield
~2.9%
Buyback Yield
~1.5%
Strengths
Concerns
P&G is a high-quality consumer staples compound with exceptional 30%+ ROE and $15.1B FCF, offering investors a 2.9% dividend yield plus ~1.5% buyback yield for total shareholder yield exceeding 4.5%. The company has reaccelerated revenue growth to 3.3% in FY2026 following a flat FY2025, though margin pressure persists with operating margin declining to 22.7%. Trading at 22x P/E with a 0.38 beta, the stock is fairly to fully valued and best suited for defensive/income mandates; new positions should be scaled on weakness toward the $137-$140 range.